TY - JOUR
T1 - Dissociative changes in the bmax and KD of dopamine D2/D3 receptors with aging observed in functional subdivisions of the striatum
T2 - A revisit with an improved data analysis method
AU - Kuwabara, Hiroto
AU - McCaul, Mary E.
AU - Wand, Gary S.
AU - Earley, Christopher J.
AU - Allen, Richard P.
AU - Weerts, Elise M.
AU - Dannals, Robert F.
AU - Wong, Dean F.
PY - 2012/5
Y1 - 2012/5
N2 - Separate measurements of Bmax, the density of available receptors, and KD, the equilibrium dissociation constant in the human brain, with PET have contributed to our understanding of neuropsychiatric disorders, especially with respect to the dopamine D2/D3 receptor system. However, existing methods have limited applications to the whole striatum, putamen, or caudate nucleus. Improved methods are required to examine B max and KD in detailed functional striatal subdivisions that are becoming widely used. Methods: In response, a new method (bolus-plusinfusion transformation [BPIT]) was developed. After completion of a validation study for 11C-raclopride scans involving 81 subjects, age-associated changes in Bmax and KD were examined in 47 healthy subjects ranging in age from 18 to 77 y. Results: The BPIT method was consistent with established reference tissue methods regarding regional binding potential. BPIT yielded time-consistent estimates of Bmax and K D when scan and infusion lengths were set equal in the analysis. In addition, BPIT was shown to be robust against PET measurement errors when compared with a widely accepted transient equilibrium method. Altogether, BPIT was supported as a method for regional binding potential, Bmax, and KD. We demonstrated ageassociated declines in Bmax in all 5 functional striatal subdivisions with BPIT when corrected for multiple comparisons. These agerelated effects were not consistently attainable with the transient equilibrium method. Irrespective to methods, KD remained unchanged with age. Conclusion: The BPIT approach may be useful for understanding dopamine receptor abnormalities in neuropsychiatric disorders by enabling separate measurements of Bmax and KD in functional striatal subdivisions.
AB - Separate measurements of Bmax, the density of available receptors, and KD, the equilibrium dissociation constant in the human brain, with PET have contributed to our understanding of neuropsychiatric disorders, especially with respect to the dopamine D2/D3 receptor system. However, existing methods have limited applications to the whole striatum, putamen, or caudate nucleus. Improved methods are required to examine B max and KD in detailed functional striatal subdivisions that are becoming widely used. Methods: In response, a new method (bolus-plusinfusion transformation [BPIT]) was developed. After completion of a validation study for 11C-raclopride scans involving 81 subjects, age-associated changes in Bmax and KD were examined in 47 healthy subjects ranging in age from 18 to 77 y. Results: The BPIT method was consistent with established reference tissue methods regarding regional binding potential. BPIT yielded time-consistent estimates of Bmax and K D when scan and infusion lengths were set equal in the analysis. In addition, BPIT was shown to be robust against PET measurement errors when compared with a widely accepted transient equilibrium method. Altogether, BPIT was supported as a method for regional binding potential, Bmax, and KD. We demonstrated ageassociated declines in Bmax in all 5 functional striatal subdivisions with BPIT when corrected for multiple comparisons. These agerelated effects were not consistently attainable with the transient equilibrium method. Irrespective to methods, KD remained unchanged with age. Conclusion: The BPIT approach may be useful for understanding dopamine receptor abnormalities in neuropsychiatric disorders by enabling separate measurements of Bmax and KD in functional striatal subdivisions.
KW - Aging
KW - C-raclopride
KW - Dopamine D/Dreceptors
KW - Functional striatal subdivisions
KW - Receptor density
UR - http://www.scopus.com/inward/record.url?scp=84860760326&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84860760326&partnerID=8YFLogxK
U2 - 10.2967/jnumed.111.098186
DO - 10.2967/jnumed.111.098186
M3 - Article
C2 - 22492734
AN - SCOPUS:84860760326
SN - 0161-5505
VL - 53
SP - 805
EP - 812
JO - Journal of Nuclear Medicine
JF - Journal of Nuclear Medicine
IS - 5
ER -